Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction.
Valdes-Marquez E. et al, (2023), Eur J Prev Cardiol
Apolipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease.
Clarke R. et al, (2023), Circ Res
Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.
Aragam KG. et al, (2022), Nat Genet
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries.
Mishra A. et al, (2022), Nature
Stroke genetics informs drug discovery and risk prediction across ancestries.
Mishra A. et al, (2022), Nature
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.
Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet, 400, 832 - 845
Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.
Clarke R. et al, (2022), Atherosclerosis, 354, 15 - 22
Independent effects of adiposity measures on risk of atrial fibrillation in men and women: a study of 0.5 million individuals.
Camm CF. et al, (2022), Int J Epidemiol, 51, 984 - 995
Multiplexed apolipoprotein profiling advances the assessment of residual lipid-related cardiovascular risk
Schmidt L. et al, (2022), CARDIOVASCULAR RESEARCH, 118
Multi-phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations.
Temprano-Sagrera G. et al, (2022), J Thromb Haemost, 20, 1331 - 1349
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
HPS3/TIMI55-REVEAL Collaborative Group None. et al, (2022), Eur Heart J, 43, 1416 - 1424
CHALLENGES IN EXTRAPOLATION WHEN THERE ARE MULTIPLE HEALTH OUTCOMES
Willliam C. et al, (2022), VALUE IN HEALTH, 25, S358 - S358
Are polygenic risk scores for systolic blood pressure and LDL-cholesterol associated with treatment effectiveness, and clinical outcomes among those on treatment?
Tapela NM. et al, (2021), Eur J Prev Cardiol
The impact of atrial fibrillation and stroke risk factors on left atrial blood flow characteristics.
Spartera M. et al, (2021), Eur Heart J Cardiovasc Imaging
Robust estimates of heritable coronary disease risk in individuals with type 2 diabetes.
Grace C. et al, (2021), Genet Epidemiol
Genome-Wide Association Study of Peripheral Artery Disease.
van Zuydam NR. et al, (2021), Circ Genom Precis Med
Impact of ACLY on type 2 diabetes in UK Biobank: a Mendelian randomisation study
Stiby A. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3011 - 3011
Impact of adverse events on quality of life and hospital costs in secondary cardiovascular disease prevention
Lui NMJ. et al, (2021), EUROPEAN HEART JOURNAL, 42, 3159 - 3159